Influence of Age on Revascularization Related Costs of Hospitalization Among Patients of Stable Coronary Artery Disease

American Journal of Cardiology

Volumn 105, Issue 11, 2010, Pages 1549-1554

  Agarwal, Shikhar ^a   Banerjee, Sudeep ^b   Tuzcu, E Murat ^a   Kapadia, Samir R ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGED; AGING; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; FEMALE; GROUPS BY AGE; HEALTH CARE DELIVERY; HEART MUSCLE REVASCULARIZATION; HOSPITAL DISCHARGE; HOSPITAL RUNNING COST; HOSPITAL UTILIZATION; HOSPITALIZATION COST; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MANAGED CARE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; UNITED STATES;

AGE FACTORS; AGED; AGED, 80 AND OVER; AGING; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; COSTS AND COST ANALYSIS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; OHIO; RISK FACTORS;

EID: 77952431050     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2010.01.012     Document Type: Article

References (16)

1. Weintraub W.S., Boden W.E., Zhang Z., Kolm P., Zefeng Z., Spertus J.A., Hartigan P., Veledkar E., Jurkovit C., Bowen J., Maron D.J., O'Rourke R., Dada M., Teo K.K., Georee R., and Barnett P.G. Cost-effectiveness of percutaneous coronary intervention in optimally treated stable coronary patients. Circ Cardiovasc Qual Outcomes 1 (2008) 12-20
2. Boden W.E., O'Rourke R.A., Teo K.K., Hartigan P.M., Maron D.J., Kostuk W.J., Knudtson M., Dada M., Casperson P., Harris C.L., Chaitman B.R., Shaw L., Gosselin G., Nawaz S., Title L.M., Gau G., Blaustein A.S., Booth D.C., Bates E.R., Spertus J.A., Berman D.S., Mancini G.B., Weintraub W.S., and COURAGE Trial Research Group. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 356 (2007) 1503-1516
3. Claude J., Schindler C., Kuster G.M., Schwenkglenks M., Szucs T., Buser P., Osswald S., Kaiser C., Grädel C., Estlinbaum W., Rickenbacher P., Pfisterer M., and Trial of Invasive Versus Medical Therapy in the Elderly (TIME) Investigators. Cost-effectiveness of invasive versus medical management of elderly patients with chronic symptomatic coronary artery disease. Findings of the randomized trial of invasive versus medical therapy in elderly patients with chronic angina (TIME). Eur Heart J 25 (2004) 2195-2203
4. Charlson M.E., Pompei P., Ales K.L., and MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40 (1987) 373-383
5. Deyo R.A., Cherkin D.C., and Ciol M.A. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. Clin Epidemiol 45 (1992) 613-619
6. United States Census Bureau. International database. Table 094. Midyear population, by age and sex. http://www.census.gov/population/www/projections/natdet-D1A.html Accessed on July 20, 2009
7. Maycock C.A., Muhlestein J.B., Horne B.D., Carlquist J.F., Bair T.L., and Pearson R.R. Statin therapy in very elderly patients with CAD. J Am Coll Cardiol 40 (2002) 1780
8. Stanton M.W., and Rutherford M.K. The High Concentration of U.S. Health Care Expenditures. AHRQ Pub. No. 06-0060 (2005), Agency for Healthcare Research and Quality, Rockville, Maryland
9. American Heart Association. Heart Disease and Stroke Statistics-2008 Update (2008), American Heart Association, Dallas, Texas
10. Weintraub W.S., Becker E.R., Mauldin P.D., Culler S., Kosinski A.S., and King III S.B. Costs of revascularization over eight years in the randomized and eligible patients in the Emory Angioplasty Versus Surgery Trial (EAST). Am J Cardiol 86 (2000) 747-752
11. Yock C.A., Boothroyd D.B., Owens D.K., Garber A.M., and Hlatky M.A. Cost effectiveness of bypass surgery versus stenting in patients with multivessel coronary artery disease. Am J Med 115 (2003) 382-389
12. Reynolds M.R., Neil N., and Ho K.K. Clinical and economic outcomes of multivessel coronary stenting compared with bypass surgery: a single-center US experience. Am Heart J 145 (2003) 334-342
13. Gorenoi V., Dintsios C.M., Schonermark M.P., and Hagen A. Health economic modeling on the use of drug eluting stents versus coronary artery bypass graft surgery in coronary heart disease. Herz 34 (2009) 231-239
14. Groeneveld P.W., Matta M.A., Greenhut A.P., and Yang F. The cost of drug-eluting coronary stents among Medicare beneficiaries. Am Heart J 155 (2008) 1097-1105
15. Grines C.L., Marsalese D.L., Brodie B., Griffin J., Donohue B., Costantini C.R., Balestrini C., Stone G., Wharton T., Esente P., Spain M., Moses J., Nobuyoshi M., Ayres M., Jones D., Mason D., Sachs D., Grines L.L., O'Neill W., and PAMI-II Investigators. Safety and cost-effectiveness of early discharge after primary angioplasty in low risk patients with acute myocardial infarction. J Am Coll Cardiol 31 (1998) 967-972
16. Leon M.B., Allocco D.J., Dawkins K.D., and Baim D.S. Late clinical events after drug-eluting stents: the interplay between stent-related and natural history-driven events. JACC Cardiovasc Interv 2 (2009) 504-512